How to best plan the key study endpoints?

How to best plan the key study endpoints?

Properly defining study endpoints is one of the most critical steps in designing a clinical trial, medical experiment, or non-interventional study. Endpoints determine what we aim to demonstrate and how we will assess the efficacy and safety of the investigational medicinal product or medical device. To be meaningful, endpoints must derive directly from the study objective, have a clear and unambiguous definition, and rely on measurable and validated parameters. Maintaining a structured hierarchy is essential—starting with the primary endpoint, followed by secondary and exploratory endpoints, which support hypothesis generation. A well-defined structure improves interpretability of results and reduces the risk of statistical errors.

It is equally important to align with current regulatory standards such as ICH E6(R3), ICH E9, and EMA or FDA guidelines. This ensures that the endpoint is not only methodologically sound but also acceptable during regulatory assessment. When planning endpoints, practical site capabilities should also be considered—equipment availability, medical staff workload, and measurement frequency. Overly complex or burdensome endpoints may reduce data quality or complicate participant recruitment.

Collaboration with a statistician is a crucial step. A biostatistician verifies whether the proposed endpoint, given the planned sample size, provides sufficient statistical power, assesses its robustness to missing data, and determines the most appropriate analytical models. It is also advisable to review previous studies or pilot data to confirm that the endpoint is realistic, reproducible, and sensitive to treatment effects.

Well-designed endpoints increase study reliability, facilitate regulatory submissions, and improve the likelihood of obtaining clear, clinically meaningful results. They represent a strategic component that can determine the overall success of a clinical project.

If you want to ensure that the endpoints planned for your study fully support its objectives, schedule a free consultation with our experts — we will help you refine the initial study concept.

Other questions: Research planning and concept

Articles

New Knowledge Base on Clinical Trials New Knowledge Base on Clinical Trials
  For several years now, the Biostat Research and Development Center has operated as a Full-Service CRO – an organization providing comprehensive support...
Voice Assistant for Doctors – A New AI Feature in the Medfile Program Voice Assistant for Doctors – A New AI Feature in the Medfile Program
Biostat's developers are launching a Voice Assistant for doctors in the Medfile software designed for medical facilities. This AI-based tool operates in ...
Clinical Trial of an Innovative Intramedullary Nail Clinical Trial of an Innovative Intramedullary Nail
The Biostat Research and Development Center will conduct a multicenter, open-label clinical trial aimed at evaluating the safety and efficacy of the Orthoget...
Copyright© 2023 Biostat